The role of versican in leiomyosarcoma pathophysiology has been established since it has been demonstrated that SK-LMS cells produce a large amount of versican so that inhibiting its synthesis leads to a reduction of both proliferation and tumor formation when these cells are injected into nude mice [44,45]. This evidence concerns the gene VCAN and neoplasm.